Premarket Approval (PMA) Agreement with FDA for the Medical Device Companies

Sign for Notice Everyday

Home Post Event 2025Event 2026Event By Topic By Country Contact

Our Sponsors

Premarket Approval (PMA) Agreement with FDA for the Medical Device Companies - Webinar by GlobalCompliancePanel

Website http://bit.ly/17nZYU2 | Edit Freely

Category Webinar, Health, Medical, Pharma, Clinical

Deadline: December 12, 2013 | Date: December 12, 2013

Venue/Country: Fremont, CA, U.S.A

Updated: 2013-11-13 15:13:31 (GMT+9)

Call For Papers - CFP

Overview: The Premarket Approval (PMA) pathway is complex. The PMA application needs to provide a reasonable assurance that the device is safe and effective for its intended use (21 USC 360e(d)(1)(A)). To do this, companies must submit valid scientific evidence (21 CFR 860.7(c)), typically derived from a clinical study. The application also needs to include documents demonstrating compliance with the Quality Systems Regulations (QSRs) (21 CFR Part 820). The PMA must also include draft labeling, information regarding product composition, preclinical data, and a summary of relevant literature (21 CFR 814.20(b)).

Once a PMA is submitted, FDA will reach a filing decision within 45 days (21 CFR 814.42(a)). The agency then has 180 days in which to complete the review. If FDA identifies major deficiencies, the 180-day review clock starts again. Before approving a PMA, FDA will generally conduct a preapproval inspection to evaluate QSR compliance.

Why Should You Attend :To gain a fundamental understanding of the Premarket Approval (PMA) process.

Areas Covered in the Session

Intended Use

Scientific Evidence

QSR Compliance

Product Labeling

FDA Review Times

Who Will Benefit:

Regulatory Affairs

Research and Development

Investigators

Regulatory professionals working in the medical device field

Thomas E. Colonna earned a bachelor of science in microbiology from the University of Sciences in Philadelphia (formerly the Philadelphia College of Pharmacy and Science), a Ph.D. in molecular biology from the Johns Hopkins University, and a law degree from the Georgetown University Law Center. In addition, Dr. Colonna holds academic appointments at Johns Hopkins University and the University of Sciences in Philadelphia.

NetZealous LLC,

DBA GlobalCompliancePanel

161 Mission Falls Lane,

Suite 216, Fremont, CA 94539, USA

USA Phone:800-447-9407

Fax: 302-288-6884

webinarsglobalcompliancepanel.com

http://www.globalcompliancepanel.com

Event Link - http://bit.ly/17nZYU2

Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.